Catalyst Wire Dossier Catalyst Wire Dossier

Nicotine Mint Lozenge 4 mg

nicotine lozenge · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nicotine Mint Lozenge 4 mg, covering 2014-06-16 to 2014-06-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation [Phase 3]

See pricing